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Friedreich ataxia	  (FRDA)	  is	  an	  autosomal	  recessive	  neuro	  and	  cardio-­‐degenerative	  disorder,	  with	  a	  
prevalence	  of	  approximately	  1	  in	  40,000	  in	  European	  populations.	  (Recent	  reviews	  include	  those	  
by	  Koeppen and	  Mazurkiewicz,1	  Collins,2	  	  and	  Gomes	  and	  Santos.3	  )	  FRDA	  is	  characterized	  by	  
progressive	  ataxia	  of	  all	  four	  limbs,	  dysarthria,	  areflexia,	  sensory	  loss,	  and	  muscle	  fatigability.	  
FRDA	  is	  caused	  by	  mutations	  in	  the	  nuclear	  gene,	  FXN	  ,	  which	  encodes	  the	  highly	  conserved	  
protein	  frataxin.	  Most	  disease	  alleles	  harbor	  a	  GAA	  repeat	  expansion	  in	  the	  first	  intron,	  which	  
results	  in	  decreased	  transcription.	  Frataxin localizes	  primarily	  to	  the	  mitochondrial	  matrix,	  where	  
it	  chaperones	  iron	  and	  regulates	  the	  iron–sulfur	  cluster	  (ISC)	  assembly	  complex.
